REFERENCES
- Chang T M. Modified hemoglobin blood substitutes: present status and future perspectives. Biotechnol Annu Rev 1998; 4: 75–112
- Rudolph A S. Encapsulated hemoglobin: current issues and future goals. Artif Cells Blood Substit Immobil Biotechnol 1994; 22: 347–360
- Maruyama K. Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol). Biochim Biophys Acta 1992; 1128: 44–49
- Bradley A J, Devine D V, Ansell S M, Janzen J, Brooks D E. Inhibition of liposome-induced complement activation by incorporated poly(ethylene glycol)-lipids. Arch Biochem Biophys 1998; 357: 185–194
- Szebeni J, Wassef N M, Hartman K R, Rudolph A S, Alving C R. Complement activation in vitro by the red cell substitute, liposome-encapsulated hemoglobin: mechanism of activation and inhibition by soluble complement receptor type 1. Transfusion 1997; 37: 150–159
- Ogata Y, Goto H, Kimura T, Fukui H. Development of Neo Red Cells (NRC) with the enzymatic reduction system of methemoglobin. Artif Cells Blood Substit Immobil Biotechnol 1997; 25: 417–427
- Niwa K, Ikebuchi K, Fujihara M, Abe H, Wakamoto S, Ito T, Yamaguchi M, Sekiguchi S. Inflammatory cytokine production in whole blood modified by liposome-encapsulated hemoglobin. Artif Cells Blood Substit Immobil Biotechnol 1998
- Fujihara M, Ikebuchi K, Yamaguchi M, Abe H, Niwa K, Sekiguchi S. Effects of liposome-encapsulated hemoglobin on phorbol ester-induced superoxide production and expression of costimulatory molecules by monocytes in vitro. Artif Cells Blood Substit Immobil Biotechnol 1998
- Klebanoff S J. Role of the superoxide anion in the myeloperoxidase-mediated antimicrobial system. J Biol Chem 1974; 249: 3724–3728
- Forman H J, Thomas M J. Oxidant production and bactericidal activity of phagocytes. Ann Rev Physiol 1986; 48: 669–680
- DeChatelet L R, Shirley P S, Johnston R B. Effect of phorbol myristate acetate on the oxidative metabolism of human polymorphonuclear leukocytes. Blood 1976; 47: 545–554
- Boxer L A, Yoder M, Bonsib S, Schmidt M, Ho P, Jersild R, Baehner R L. Effects of a chemotactic factor, N-formylmethionyl peptide, on adherence, superoxide anion generation, phagocytosis, and microtubule assembly of human polymorphonuclear leukocytes. J Lab Clin Med 1979; 93: 506–514
- Yuo A, Kitagawa S, Kasahara T, Matsushima K, Saito M, Takaku F. Stimulation and priming of human neutrophils by interleukin-8: cooperation with tumor necrosis factor and colony-stimulating factors. Blood 1991; 78: 2708–2714
- Tanaka T, Kanegasaki S, Makino R, Iizuka T, Ishimura Y. Saturated and trans-unsaturated fatty acids elicit high levels of superoxide generation in intact and cell-free preparations of neutrophils. Biochem Biophys Res Commun 1987; 144: 606–612
- Kuwabara M, Yamamoto T, Inanami O, Sato F. Mechanism of photosensitization by pheophorbide a studied by photohemolysis of erythrocytes and electron spin resonance spectroscopy. Photochem Photobiol 1989; 49: 37–41
- Nebot C, Moutet M, Huet P, Xu J Z, Yadan J C, Chaudiere J. Spectrophotometric assay of superoxide dismutase activity based on the activated autoxidation of a tetracyclic catechol. Anal Biochem 1993; 214: 442–451
- Goins B, Phillips W T, Klipper R. Blood-pool imaging using technetium-99m-labeled liposomes. J Nucl Med 1996; 37: 1374–1379
- Somiya K, Niwa Y, Michelson A M. Effects of liposomal superoxide dismutase on human neutrophil activity. Free Radic Res Commun 1986; 1: 329–337
- Razack S, D'Agnillo F, Chang T M. Crosslinked hemoglobin-superoxide dismutase-catalase scavenges free radicals in a rat model of intestinal ischemia-reperfusion injury. Artif Cells Blood Substit Immobil Biotechnol 1997; 25: 181–192
- D'Agnillo F, Chang T. Absence of hemoprotein-associated free radical events following oxidant challenge of crosslinked hemoglobin-superoxide dismutase catalase. Free Radical Biol Med 1998; 24: 906–912
- Chang T M, D'Agnillo F, Yu W P, Razack S. Two future generations of blood substitutes based on polyhemoglobin-SOD-catalase and nanoencapsulation. Adv Drug Deliv Rev 2000; 40: 213–218